(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.36%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally...
Stats | |
---|---|
Šios dienos apimtis | 436 657 |
Vidutinė apimtis | 1.71M |
Rinkos kapitalizacija | 6.50M |
EPS | $0 ( 2024-04-03 ) |
Kita pelno data | ( $-0.0900 ) 2024-05-20 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.0800 |
ATR14 | $0.00500 (0.98%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-23 | Lazar David E. | Buy | 150 000 | Series E Convertible Preferred Stock |
2024-04-11 | Ben-tzvi Avraham | Buy | 100 000 | Common Stock |
2024-04-11 | Natan David | Buy | 100 000 | Common Stock |
2024-04-11 | Mcmurdo Matthew Charles | Buy | 100 000 | Common Stock |
2024-04-11 | Lazar David E. | Buy | 100 000 | Common Stock |
INSIDER POWER |
---|
-71.10 |
Last 97 transactions |
Buy: 3 573 408 | Sell: 6 921 404 |
Tūris Koreliacija
OpGen Inc Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
OpGen Inc Koreliacija - Valiuta/Žaliavos
OpGen Inc Finansinės ataskaitos
Annual | 2022 |
Pajamos: | $2.61M |
Bruto pelnas: | $-816 698 (-31.32 %) |
EPS: | $-15.05 |
FY | 2022 |
Pajamos: | $2.61M |
Bruto pelnas: | $-816 698 (-31.32 %) |
EPS: | $-15.05 |
FY | 2021 |
Pajamos: | $4.31M |
Bruto pelnas: | $1.46M (33.85 %) |
EPS: | $-2.20 |
FY | 2020 |
Pajamos: | $4.21M |
Bruto pelnas: | $365 950 (8.68 %) |
EPS: | $-1.660 |
Financial Reports:
No articles found.
OpGen Inc
OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits. The company's products also comprise ARES Technology Platform, including ARES reference database on antimicrobial resistance using next generation sequencing technology and artificial intelligence powered bioinformatics solutions for antibiotic response prediction; and Unyvero Platform, an automated sample-to-answer molecular diagnostics platform that integrates automated sample preparation, analysis, and identification of disease relevant pathogens and antibiotic resistance markers. The company utilizes molecular diagnostics and informatics to help combat infectious diseases. It also helps clinicians with information about life threatening infections to enhance patient outcomes, and to decrease the spread of infections caused by multidrug-resistant microorganisms. OpGen, Inc. has a collaboration with the New York State Department of Health and ILÚM Health Solutions, LLC to develop a research program to detect, track, and manage antimicrobial-resistant infections at healthcare institutions. The company was incorporated in 2001 and is headquartered in Rockville, Maryland.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.